Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.11, 2002-11, pp. : 1589-1598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

I_Kur/Kv1.5 channel blockers for the treatment of atrial fibrillation

By Tamargo Juan Caballero Ricardo Gómez Ricardo Delpón Eva

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 399-416

Informa Healthcare

Access to resources Recommend Favorite

Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo Pharmacology

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 436-451

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 16, 2016-07 ,pp. : 1843-1854

Bentham Science Publishers

Access to resources Recommend Favorite

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

By Wulff Heike

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1759-1765

Informa Healthcare

Access to resources Recommend Favorite

Drug Discoveries Towards Kv1.5 Potassium Channel

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 339-347

Bentham Science Publishers

Access to resources Recommend Favorite